Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Shanghai Genechem Co., Ltd. (Genechem) announces global collaboration on bispecific antibodies
Thursday, April 08, 2021Shanghai Genechem Co Ltd Genechem a discovery company dedicated to the discovery of new drug targets and the development of new therapeutic products today announced the conclusion of a global collaboration with IMab
Progenity and Ionis Pharmaceuticals Enter into Agreement to Evaluate Progenity’s Ingestible Oral Biotherapeutics Technology for Delivery of Antisense Therapies
Thursday, April 08, 2021Progenity Inc a biotechnology company with an established track record of success developing and commercializing molecular testing products today announced an agreement with Ionis Pharmaceuticals the leader in RNAtargeted therapeutics to evaluate the...
Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy
Thursday, April 08, 2021MyBiotics Pharma Ltd a microbiome therapeutics company and Hadasit Medical Research Services and Development Ltd the technology transfer office of Hadassah Medical Center announced that they have entered into a research collaboration and licensing ag...
Cidara Therapeutics Announces Agreement with Janssen to Develop and Commercialize AVCs for the Prevention and Treatment of Influenza
Tuesday, April 06, 2021Cidara Therapeutics Inc a biotechnology company developing longacting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections announced that it has entered into an exclusive worldwide license and...
Sorrento Enters Into Merger Agreement to Acquire Late-Stage Oncology Company ACEA Therapeutics
Tuesday, April 06, 2021Sorrento Therapeutics Incannounced the signing of a merger agreement pursuant to which Sorrento will acquire ACEA Therapeutics Inc ACEA The acquisition will include late clinical stage drug Abivertinib clinical stage candidate AC preclinical stage ca...
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
Saturday, April 03, 2021Supernus Pharmaceuticals Inc a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system CNS diseases today announced that the US Food and Drug Administration FDA approved Qelbree viloxaz...
Emergent BioSolutions Announces Topline Data from NIAID Phase 3 ITAC Trial (INSIGHT-013) Evaluating Immunoglobulins as a Treatment for Hospitalized Patients with COVID-19
Saturday, April 03, 2021Emergent BioSolutions Inc provided an update on the evaluation of its investigational SARSCoV Immune Globulin Intravenous Human COVIDHIG for the treatment of hospitalized patients with COVID The Phase Inpatient Treatment with AntiCoronavirus Immunog...
Bioasis Technologies Inc. and Aposense Enter into a Research Collaboration
Thursday, April 01, 2021Bioasis Technologies Inc a preclinical researchstage biopharmaceutical company developing its proprietary xB TM platform technology for the delivery of therapeutics across the bloodbrain barrier BBB and the treatment of CNS disorders in areas of high...
BridgeBio Pharma’s Affiliate QED Therapeutics and Helsinn Group Announce Strategic Collaboration to Co-Develop and Commercialize Infigratinib in Oncology
Thursday, April 01, 2021BridgeBio Pharma Inc through its affiliate QED Therapeutics Inc and Helsinn Group announced a global collaboration and licensing agreement the Agreement to further develop and commercialize QED Therapeutics FGFR inhibitor infigratinib in oncology an...
BridGene Biosciences Announces Research Collaboration with Takeda to Discover Small Molecule Drugs for "Undruggable" Targets
Wednesday, March 31, 2021BridGene Biosciences Inc a biotechnology company using cuttingedge technology to discover and develop small molecules for hardtodrug therapeutic targets announced a strategic research collaboration and licensing agreement with Takeda Pharmaceutical C...
